Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography studies in cancer patients

Molecular Imaging and Biology

Volumn 7, Issue 3, 2005, Pages 229-235

  Yeung, Henry W D ^a   Schöder, Heiko ^a   Smith, Alex ^a   Gonen, Mithat ^a   Larson, Steven M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

FDG PET scan in oncology; PET CT

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ABDOMINAL TUMOR; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PELVIS TUMOR; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THORAX TUMOR; TUMOR LOCALIZATION; CHILD; MIDDLE AGED; NEOPLASM; PATHOLOGY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 24744442837     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-005-4113-y     Document Type: Article

References (13)

1. R Hustinx F Benard A Alavi 2002 Whole-body FDG-PET imaging in the management of patients with cancer Semin Nucl Med 32 35-46 11839068
2. JB Bomanji DC Costa PJ Ell 2001 Clinical role of positron emission tomography in oncology Lancet Oncol 2 157-164 10.1016/ S1470-2045(00)00257-6 1:STN:280:DC%2BD387ntFeltg%3D%3D 11902566
3. E Bombardieri I Carrio P Gonzalez et al. 1999 Current applications and perspectives of diagnostic nuclear medicine in oncology. Task Group of Oncology Int J Oncol 14 877-890 1:STN:280:DyaK1M3hvVeltQ%3D%3D 10200337
4. V Bettinardi E Pagani MC Gilardi et al. 1999 An automatic classification technique for attenuation correction in positron emission tomography Eur J Nucl Med 26 447-458 10.1007/s002590050410 1:STN:280:DyaK1MzhtFSqtA%3D%3D 10382087
5. T Beyer DW Townsend T Brun et al. 2000 A combined PET/CT scanner for clinical oncology J Nucl Med 41 1369-1379 1:STN:280:DC%2BD3cvitFCguw%3D%3D 10945530
6. A Trojan M Jermann C Taverna TF Hany 2002 Fusion PET-CT imaging of neurolymphomatosis Ann Oncol 13 802-805 10.1093/annonc/mdf057 1:STN:280:DC%2BD38zjtlWqtA%3D%3D 12075752
7. S Makhija N Howden R Edwards J Kelley DW Townsend CC Meltzer 2002 Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: A retrospective review Gynecol Oncol 85 53-58 10.1006/gyno.2002.6606 1:STN:280:DC%2BD387pt1ejsQ%3D%3D 11925120
8. P Kluetz C Meltzer V Villemagne et al. 2000 Combined PET/CT imaging in oncology. Impact on patient management Clin Positron Imaging 3 223-230 10.1016/S1095-0397(01)00055-3 11378434
9. T Hany H Steinert G Goerres A Buck G Schulthess von 2002 PET diagnostic accuracy: Improvement with in-line PET-CT system: Initial results Radiology 225 575-581
10. D Lardinois W Weder TF Hany et al. 2003 Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2500-2507 12815135
11. M Gonen KS Panageas SM Larson 2001 Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient Radiology 221 763-767 1:STN:280:DC%2BD3Mnntlyjsw%3D%3D 11719674
12. C Cohade M Osman Y Nakamoto et al. 2003 Initial experience with oral contrast in PET/CT: Phantom and clinical studies J Nucl Med 44 412-416 12621008
13. GW Goerres E Kamel B Seifert et al. 2002 Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system J Nucl Med 43 1469-1475 12411550